Status | Study |
Recruiting |
Study Name: sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2014-10-09 Interventions: Procedure: Lumbar puncture Lum |
Active, not recruiting |
Study Name: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Condition: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Polyradiculon Date: 2014-01-03 Interventions: Biological: IgPro20 |
Completed |
Study Name: MRI in Diagnosing and Monitoring CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2013-12-06 |
Withdrawn |
Study Name: Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Condition: Chronic Inflammatory Demyelinating Neuropathy Date: 2012-12-06 Interventions: Drug: Alemtuzumab infusion |
Completed |
Study Name: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2012-06-19 Interventions: Drug: Fingolimod Drug: Placebo Comparator |
Completed |
Study Name: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Condition: Chronic Inflammatory Demyelinating Polyneuropathy Polyradiculoneuropat Date: 2012-03-01 Interventions: Biological: IgPro20 |
Not yet recruiting |
Study Name: Perception and Multisensory Integration in Neurological Patients Using fMRI Condition: Acute Inflammatory Demyelinating Polyradiculoneuropathy Myasthe Date: 2011-11-01 Interventions: Device: Siemens magnetom avanto1.5 Tesla, Siemens magnetom trio A Tim system 3 Tesla functional magnetic |
Terminated |
Study Name: Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2010-10-06 Interventions: Drug: NewGam 10% Loading dose |
Completed |
Study Name: Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2009-11-06 Interventions: Drug: Subcutaneous immunoglobulin The subcutaneous immunoglobulin is infused in the subcutaneous tissue |
Completed |
Study Name: Study of CIDP Patients During IVIG Treatment Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2006-03-20 Interventions: Drug: intravenous gammaglobulin individual dose |